Susquehanna International Group, LLP Concert Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.34 - $5.84 $880,069 - $1.18 Million	202,781 Added 542.06%	240,190 $1.4 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $159,736 - $269,344	37,409 New	37,409 $251,000
Q1 2022 May 16, 2022	SELL	$2.73 - $3.94 $97,783 - $141,122	-35,818 Reduced 69.83%	15,476 $52,000
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.15 $75,820 - $99,259	-23,918 Reduced 31.8%	51,294 $168,000
Q2 2021 Aug 11, 2021	BUY	$3.77 - $5.24 $236,412 - $328,595	62,709 Added 501.55%	75,212 $317,000

Q1 2021 May 17, 2021	SELL	$4.86 - $13.07 $37,694 - $101,370	-7,756 Reduced 38.28%	12,503 $62,000
Q4 2020 Feb 16, 2021	BUY	$9.48 - $12.84 $192,055 - $260,125	20,259 New	20,259 $256,000
Q2 2020 Aug 14, 2020	SELL	$7.8 - $11.52 $141,741 - $209,341	-18,172 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.98 - $13.09 $24,147 - $52,857	4,038 Added 28.57%	18,172 $161,000
Q4 2019 Feb 14, 2020	SELL	$5.71 - $9.22 $106,959 - $172,709	-18,732 Reduced 57.0%	14,134 $130,000
Q3 2019 Nov 14, 2019	BUY	$5.88 - $12.35 $82,984 - $174,295	14,113 Added 75.26%	32,866 $193,000
Q2 2019 Aug 16, 2019	BUY	$9.44 - $13.12 $19,059 - $26,489	2,019 Added 12.07%	18,753 $225,000
Q2 2019 Aug 14, 2019	SELL	$9.44 - $13.12 $26,752 - $37,182	-2,834 Reduced 14.48%	16,734 $201,000
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $367,470 - $528,176	-32,664 Reduced 62.54%	19,568 $246,000
Q4 2017 Feb 14, 2018	BUY	$13.96 - $29.05 $729,158 - $1.52 Million	52,232	52,232 $1.35 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.